Table 4 Characteristics and Strain Parameters of CS Patients With Normal LV and RV Function and Control Patients Without CSa
From: Diagnostic and predictive value of speckle tracking echocardiography in cardiac sarcoidosis
Variable | CS Patients with LVEF > 52% (men) and > 54% (women) (n = 23) | Control Patients (N = 97) | P Value |
|---|---|---|---|
Age, y | 52.9 ± 10.0 | 40.4 ± 13.6 | .0001 |
Female sex, No. (%) | 5 (21.7) | 61 (62.9) | .0001 |
BMI, kg/m2 | 29.9 ± 4.7 | 25.9 ± 4.8 | .001 |
Systolic BP, mm Hg | 123.3 ± 16.5 | 115.6 ± 15.5 | .05 |
Diastolic BP, mm Hg | 71.6 ± 7.2 | 71.2 ± 9.8 | .81 |
Heart rate, bpm | 75.3 ± 20.4 | 72.7 ± 13.3 | .45 |
LV mass indexed for BSA, g/m2 | 92.7 ± 22.9 | 76.7 ± 13.6 | .0001 |
LVEF, % | 57.3 ± 3.8 | 63.9 ± 3.8 | .0001 |
E/A | 1.1 ± 0.6 | 1.6 ± 0.6 | .001 |
E/e′ | 9.2 ± 4.4 | 7.7 ± 1.9 | .01 |
LV GLS, % | −15.9 ± 2.5 | −18.2 ± 2.7 | .001 |
LV GCS, % | −22.5 ± 4.7 | −21.9 ± 4.7 | .60 |
LV GRS, % | 37.1 ± 13.1 | 44.1 ± 12.1 | .02 |
LV GLSR, s−1 | −1.0 ± 1.2 | −1.0 ± 0.2 | .27 |
LV GCSR, s−1 | −1.5 ± 0.4 | − 1.4 ± 0.3 | .22 |
LV GRSR, s−1 | 2.0 ± 0.4 | 2.2 ± 0.6 | .09 |
LV GLSRe, s−1 | 0.9 ± 0.2 | 1.1 ± 0.2 | .004 |
LV GCSRe, s−1 | 1.6 ± 0.6 | 1.4 ± 0.3 | .08 |
LV GRSRe, s−1 | −1.4 ± 1.3 | −2.1 ± 0.8 | .002 |
RV GLS, % | −16.9 ± 4.5 | −24.1 ± 4.0 | .0001 |
RV GLSR, s−1 | − 1.1 ± 0.3 | −1.4 ± 0.3 | .0001 |
RV GLSRe, s−1 | 1.0 ± 0.3 | 1.5 ± 0.4 | .0001 |
RV free wall GLS, % | −19.1 ± 5.1 | −26.0 ± 5.2 | .0001 |
RV free wall GLSR, s−1 | − 1.3 ± 0.4 | −1.6 ± 0.4 | .003 |
RV free wall GLSRe, s−1 | 1.1 ± 0.4 | 1.9 ± 0.8 | .0001 |